Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Transcatheter arterial chemoembolization and radiation therapy for treatment-naïve patients with locally advanced hepatocellular carcinoma.

Kim SW, Oh D, Park HC, Lim DH, Shin SW, Cho SK, Gwak GY, Choi MS, Paik YH, Paik SW.

Radiat Oncol J. 2014 Mar;32(1):14-22. doi: 10.3857/roj.2014.32.1.14. Epub 2014 Mar 27.

3.
4.

The feasibility of combined transcatheter arterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma.

Cho JY, Paik YH, Park HC, Yu JI, Sohn W, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.

Liver Int. 2014 May;34(5):795-801. doi: 10.1111/liv.12445. Epub 2014 Jan 12.

PMID:
24350564
5.

Transcatheter arterial chemoembolization for infiltrative hepatocellular carcinoma: clinical safety and efficacy and factors influencing patient survival.

Han K, Kim JH, Yoon HM, Kim EJ, Gwon DI, Ko GY, Yoon HK, Ko HK.

Korean J Radiol. 2014 Jul-Aug;15(4):464-71. doi: 10.3348/kjr.2014.15.4.464. Epub 2014 Jul 9.

6.

Unresectable hepatocellular carcinoma treated with radiotherapy and/or chemoembolization.

Chia-Hsien Cheng J, Chuang VP, Cheng SH, Lin YM, Cheng TI, Yang PS, Jian JJ, You DL, Horng CF, Huang AT.

Int J Cancer. 2001 Aug 20;96(4):243-52.

7.

Local radiotherapy with or without transcatheter arterial chemoembolization for patients with unresectable hepatocellular carcinoma.

Cheng JC, Chuang VP, Cheng SH, Huang AT, Lin YM, Cheng TI, Yang PS, You DL, Jian JJ, Tsai SY, Sung JL, Horng CF.

Int J Radiat Oncol Biol Phys. 2000 May 1;47(2):435-42.

PMID:
10802371
8.

A prospective phase 2 multicenter study for the efficacy of radiation therapy following incomplete transarterial chemoembolization in unresectable hepatocellular carcinoma.

Choi C, Koom WS, Kim TH, Yoon SM, Kim JH, Lee HS, Nam TK, Seong J.

Int J Radiat Oncol Biol Phys. 2014 Dec 1;90(5):1051-60. doi: 10.1016/j.ijrobp.2014.08.011. Epub 2014 Oct 8.

PMID:
25303890
9.

[Three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma].

Zhou ZH, Liu LM, Cheng WW, Meng ZQ, Lin JH, Chen Z, Zhang XJ, Jiang GL.

Zhonghua Zhong Liu Za Zhi. 2006 Mar;28(3):222-6. Chinese.

PMID:
16875612
10.
11.

Comparison of combination therapies in the management of hepatocellular carcinoma: transarterial chemoembolization with radiofrequency ablation versus microwave ablation.

Ginsburg M, Zivin SP, Wroblewski K, Doshi T, Vasnani RJ, Van Ha TG.

J Vasc Interv Radiol. 2015 Mar;26(3):330-41. doi: 10.1016/j.jvir.2014.10.047. Epub 2014 Dec 18.

12.

Hepatocellular Carcinoma: A Phase II Randomized Controlled Double-Blind Trial of Transarterial Chemoembolization in Combination with Biweekly Intravenous Administration of Bevacizumab or a Placebo.

Pinter M, Ulbrich G, Sieghart W, Kölblinger C, Reiberger T, Li S, Ferlitsch A, Müller C, Lammer J, Peck-Radosavljevic M.

Radiology. 2015 Dec;277(3):903-12. doi: 10.1148/radiol.2015142140. Epub 2015 Jul 1.

PMID:
26131911
13.
15.

Combined therapy of transcatheter arterial chemoembolisation and three-dimensional conformal radiotherapy for hepatocellular carcinoma.

Zhou ZH, Liu LM, Chen WW, Men ZQ, Lin JH, Chen Z, Zhang XJ, Jiang GL.

Br J Radiol. 2007 Mar;80(951):194-201. Epub 2006 Oct 12.

PMID:
17038412
16.

Local radiotherapy for unresectable hepatocellular carcinoma patients who failed with transcatheter arterial chemoembolization.

Seong J, Park HC, Han KH, Lee DY, Lee JT, Chon CY, Moon YM, Suh CO.

Int J Radiat Oncol Biol Phys. 2000 Jul 15;47(5):1331-5.

PMID:
10889387
17.

Safety and effectiveness of chemoembolization with drug-eluting beads for advanced-stage hepatocellular carcinoma.

Kalva SP, Pectasides M, Liu R, Rachamreddy N, Surakanti S, Yeddula K, Ganguli S, Wicky S, Blaszkowsky LS, Zhu AX.

Cardiovasc Intervent Radiol. 2014 Apr;37(2):381-7. doi: 10.1007/s00270-013-0654-7. Epub 2013 Jun 12.

PMID:
23754191
18.

Combined transcatheter arterial chemoembolization and local radiotherapy of unresectable hepatocellular carcinoma.

Seong J, Keum KC, Han KH, Lee DY, Lee JT, Chon CY, Moon YM, Suh CO, Kim GE.

Int J Radiat Oncol Biol Phys. 1999 Jan 15;43(2):393-7.

PMID:
10030267
19.

The combination of transcatheter arterial chemoembolization and sorafenib is well tolerated and effective in Asian patients with hepatocellular carcinoma: final results of the START trial.

Chao Y, Chung YH, Han G, Yoon JH, Yang J, Wang J, Shao GL, Kim BI, Lee TY.

Int J Cancer. 2015 Mar 15;136(6):1458-67. doi: 10.1002/ijc.29126. Epub 2014 Sep 16.

20.

Analysis of survival factors in patients with intermediate-advanced hepatocellular carcinoma treated with transcatheter arterial chemoembolization combined with sorafenib.

Zheng J, Shao G, Luo J.

Clin Transl Oncol. 2014 Nov;16(11):1012-7. doi: 10.1007/s12094-014-1189-3. Epub 2014 Jun 4.

PMID:
24894839

Supplemental Content

Support Center